Medicine guide

NUVAXOVID XBB.1.5

As listed in the register: NUVAXOVID XBB.1.5, dispersion injectable. Vaccin contre la COVID-19 (recombinant, avec adjuvant)

5 microgrammes · dispersion injectable

  • Prescription only
Made by
SANOFI WINTHROP INDUSTRIE

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made bySANOFI WINTHROP INDUSTRIE
Active substanceProtéine Spike (S) Recombinante Du Sars-Cov-2, Variant Omicron Xbb.1.5
Strength5 microgrammes
Formdispersion injectable
Routeintramusculaire
Dispensing (as stated by the register)liste I
MarketedNo — authorised but not currently marketed, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/21/1618
Name in the registerNUVAXOVID XBB.1.5, dispersion injectable. Vaccin contre la COVID-19 (recombinant, avec adjuvant)
Packs2 flacons multidoses en verre de 2,5 mL de 5 doses (10 doses)
CIS65689785
CIP133400930277409

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).